Second, since study population was enrolled before angiotensin receptor neprilysin inhibitor and sodium glucose cotransporter 2 inhibitors were clinically applied for HF in Japan, we could not examine the impact of these medicines on malnutrition, renal dysfunction and clinical outcomes. The gene discussed is SLC5A2; the disease is nutritional deficiency disease.